Healthtech startup Medicardia closes $3m post seed round to accelerate growth
Medicardia Health announced it has raised $3 million in its first major financing round. Founded in 2020, the company was initially bootstrapped by CEO and Founder Indrajit Choudhuri and associates, and was provided seed capital by veteran angel investor Jeff Rusinow, now Chairman.
With the new funds, the company will significantly ramp up further IT development of its core digital health platform, which includes embedded telehealth, remote patient monitoring (RPM), natural language processing (NLP) for data discretization, and automated chart preparation. New features on the MediCardia platform set to launch in the coming months will include integration for implantable devices, imaging, a research platform, and a proprietary clinical intelligence engine.
Jeff Rusinow, Angel Investor, Medicardia: "In the past two years, we have launched our MediCardia digital health platform with applications available to a wide array of clinicians with a focus on dramatically improving the user interface, improving outcomes, reducing expenses and increasing revenue while improving clinical efficacy. MediCardia is now positioned for rapid growth."
The fundraising round was joined by prominent angel investors in Wisconsin (including Milwaukee Venture Partners) and throughout the U.S., as well as Japan. In addition, MediCardia received funding from Northwestern Mutual Cream City Venture Capital.
MediCardia will soon begin approaching VCs and strategic partners in preparing for a Series A funding round in 2022.